Stocks
Atara Biotherapeutics (ATRA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -2.12 | -3.25 | -3.41 | -0.76 | -0.23 | 0.18 | ||
| Changes by years, y/y, % | -99% | +53% | +5% | -78% | -70% | -73.0% | |||
Atara Biotherapeutics. EV/EBITDA
Atara Biotherapeutics. EV/EBITDA, changes, %
Atara Biotherapeutics (ATRA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -0.41 | -0.23 | -0.64 | -0.41 | -0.23 | 0.18 | |
| Changes by years, y/y, % | -99% | -99% | -97% | -92% | -44% | |||
| Changes by quarters, q/q, % | -92% | -44% | +182% | -37% | -44% | |||
